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Quantification of Hepatic Transaldolase Exchange
Activity and Its Effects on Tracer Measurements of
Indirect Pathway Flux in Humans
John G. Jones,1* Paula Garcia,2 Cristina Barosa,1 Teresa C. Delgado,1
M. Madalena Caldeira,3 and Luisa Diogo2
Exchange of hepatic glucose-6-phosphate (G6P) and glyceral-
dehyde-3-phosphate via transaldolase modifies hepatic G6P
enrichment from glucose or gluconeogenic tracers. Transaldo-
lase exchange was quantified in five healthy, fed subjects fol-
lowing an oral bolus of [1,2,3-13C3]glycerol (25–30 mg/kg) and
paracetamol (10–12 mg/kg). 13C Isotopomers of hepatic G6P
were quantified by 13C NMR spectroscopy of urinary glucuro-
nide. [1,2,3-13C3]- and [4,5,6-13C3]glucuronide isotopomers, rep-
resenting the conversion of [1,2,3-13C3]glycerol to G6P via dihy-
droxyacetone phosphate, were resolved from [1,2-13C2]- and
[5,6-13C2]glucuronide 13C-isotopomers, derived from metabo-
lism of [1,2,3-13C3]glycerol via pyruvate and phosphoenolpyru-
vate. Enrichment of [1,2,3-13C3]glucuronide was significantly
less than that of [4,5,6-13C3]glucuronide (1.30  0.57% versus
1.67  0.42%, P < 0.05). Also, [1,2-13C2]glucuronide enrichment
was significantly less than that of [5,6-13C2]glucuronide (0.28 
0.08% versus 0.36  0.03%, P < 0.05). Transaldolase and triose
phosphate isomerase exchange activities were estimated by
applying the 13C-isotopomer data to a model of hepatic sugar
phosphate metabolism. Triose phosphate isomerase exchange
was 99% complete and did not contribute significantly to the
unequal 13C-isotopomer distributions of the glucuronide triose
halves. Instead, this was attributable to 25  23% of hepatic
G6P flux undergoing transaldolase exchange. This results in
substantial overestimates of indirect pathway contributions to
hepatic glycogen synthesis with tracers such as [5-3H]glucose
and 2H2O. Magn Reson Med 59:423–429, 2008. © 2008 Wiley-
Liss, Inc.
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Hepatic glucose-6-phosphate (G6P) lies at the metabolic
crossroads of hepatic glucose and glycogen metabolism.
Under fasting conditions when the liver is a net producer
of glucose, hepatic G6P is generated by the hydrolysis of
glycogen and from gluconeogenesis and is then converted
to glucose via G6P. Under fed conditions there is net
hepatic glycogen synthesis from both glucose and from
gluconeogenic precursors. These metabolic pathways con-
verge at G6P and the hexose carbon skeletons are then
incorporated into glycogen via glucose-1-phosphate and
UDP-glucose. The gluconeogenic contribution to G6P syn-
thesis is modified in a variety of human diseases, includ-
ing insulin- and noninsulin-dependent diabetes, cirrhosis,
and malaria (1–4). Therefore, quantifying the fraction of
G6P derived from gluconeogenesis is a key parameter for
defining hepatic carbohydrate metabolism under these and
other pathophysiological conditions. In humans, several
different tracer methods have been developed for quanti-
fying the contribution of gluconeogenesis to hepatic G6P
flux. Hepatic G6P enrichment from these tracers can be
quantified noninvasively by analysis of urinary glucuro-
nide enrichment (5–7).
Implicit in all measurements of hepatic gluconeogenesis
using labeled gluconeogenic substrates is the assumption
that G6P molecules derived from non-gluconeogenic pre-
cursors (i.e., glycogenolysis) are not labeled with the trac-
er.1 Likewise, when labeled glucose is used to determine
the contribution of direct and indirect pathways of hepatic
glycogen synthesis under fed conditions, dilution of the
glucose tracer at the level of hepatic G6P is assumed to be
entirely due to gluconeogenic G6P production.
The possibility that transaldolase (TA) exchange could
invalidate these assumptions was recognized by Landau
and co-workers (8–10). TA catalyzes the exchange be-
tween the glyceraldehyde-3-phosphate (GA3P) moiety
(i.e., carbons 4, 5, and 6) of fructose-6-phosphate (F6P) and
free GA3P in many tissues (11–13). This exchange is inde-
pendent of oxidative pentose phosphate pathway (PPP)
flux, hence tissues that have relatively low oxidative PPP
utilization of G6P, such as liver, may nevertheless have
significant TA exchange activity (13). Since G6P and F6P
are in rapid exchange, G6P molecules derived from glu-
cose or glycogen are exposed to TA activity. With glu-
coneogenic tracers that label GA3P, the effect of TA ex-
change is to transfer the label to G6P molecules derived
from glucose or glycogen. Hence, the gluconeogenic con-
tribution is overestimated relative to the contribution from
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glucose or glycogen. Under fed conditions, when the con-
tribution of glucose via the direct pathway to G6P synthe-
sis is quantified with a tracer such as [5-3H]glucose, TA
exchange depletes the amount of [5-3H]G6P resulting in an
underestimate of the direct pathway fraction and a corre-
sponding overestimate of the gluconeogenic (indirect)
pathway contribution to G6P flux (10).
The extent of TA activity in human liver during either
the fed or fasting state is not known. We present new
observations of glucuronide 13C-isotopomer distributions
that are best explained by the presence of TA exchange.
We developed a metabolic model that relates the 13C-iso-
topomer distributions of glucuronide to TA exchange. Fol-
lowing ingestion of [1,2,3-13C3]glycerol, human glucuro-
nide 13C-isotopomer distributions were quantified by 13C
NMR and the extent of TA exchange for the hepatic G6P
pool was estimated. Our results indicate that a substantial
fraction of hepatic G6P undergoes TA exchange in healthy,
fed humans. Failure to account for this activity could
result in a significant overestimation of the indirect path-
way contribution to hepatic glycogen synthesis with some




Human studies were performed according to study proto-
cols approved by the Ethics Committees of the University
and Pediatrics Hospitals of Coimbra after informed con-
sent was obtained from the subjects. Five healthy nono-
bese subjects (1 male, 4 females; 20  4 years; 53  13 kg)
were studied. After an overnight fast, at 08:00, 11:00, and
14:00 subjects ingested 1 g/kg body weight of cornstarch as
an aqueous slurry. Paracetamol (10–12 mg/kg) was also
ingested at 11:00 and the cornstarch meal at 14:00 was
accompanied by phenylbutyric acid (5 mg/kg) and [1,2,3-
13C3]glycerol (25–30 mg/kg). Blood (10 mL) was collected
at 17:00 and urine was collected from 16:45–18:45.
Sample Processing
Urine was concentrated to 10% of its original volume and
this portion was mixed with 9 volumes of 100% ethanol.
The precipitate was centrifuged, the supernatant was
evaporated to10 mL, and the pH was adjusted to 8.0–9.0
with 1 M NaOH. The supernatant was applied to a 18 
1 cm diameter Dowex-1X8-200-acetate column. The col-
umn was washed with 35 mL of water, the glucuronide
eluted with 35 mL of 10 M acetic acid, and the acetic acid
fraction was evaporated to dryness at 40–50°C. The resi-
due was resuspended in 50 mL water and the pH was
adjusted to 4.5–5.0.
Paracetamol glucuronide in this solution was derivat-
ized to monoacetoneglucuronic lactone (MAGL) as previ-
ously described (14). Two thousand units of -glucuroni-
dase (H. Pomatia, Sigma Chemical, St. Louis, MO) were
added and the solution was incubated at 45°C for 48 hr.
The solution was then passed through 10 mL Dowex-
50X8-200 H ion-exchange resin and evaporated to com-
plete dryness at 40°C, resulting in the conversion of free
glucuronic acid to glucuronolactone. The lactone was con-
verted to MAGL by stirring for 24 hr with 5 mL of anhy-
drous acetone and 0.1 mL concentrated H2SO4. The yellow
solution was mixed with 5 mL water, the pH adjusted to
between 4 and 5 with 0.5 M Na2CO3, and the solution
evaporated to dryness at room temperature. MAGL was
extracted from the salt products with 2–3 mL acetonitrile.
For 13C NMR analysis the acetonitrile supernatant was
evaporated to dryness and the residue was resuspended in
0.6 mL of 20% deuterated acetonitrile.
NMR Spectroscopy
Proton-decoupled 13C NMR spectra were obtained with an
11.75T Varian Unity spectrometer equipped with a 5-mm
broadband probe. Spectra were acquired with a 60° pulse
angle, an acquisition time of 2.5 sec, a sweep width of
25 kHz, and a pulse delay of 0.5 sec. The number of
acquisitions ranged from 8,000–20,000 (6.7–16.7 hr). The
summed free induction decays were processed with 0.1–
0.2 Hz line broadening. All NMR spectra were analyzed
using the curve-fitting routine supplied with the NUTS
PC-based NMR spectral analysis program (Acorn NMR,
Fremont CA). 13C chemical shifts were referenced to the
methyl carbon of nondeuterated acetonitrile at 0.3 ppm.
Metabolic Model
The metabolic model relating the formation of G6P 13C-
isotopomers from 13C-triose phosphate precursors to met-
abolic exchange and dilution parameters is shown in Fig.
1. The model assumes negligible flux through the oxida-
FIG. 1. Metabolic model for the metabolism of [1,2,3-13C3]glycerol
to UDP-glucose (UDPG) during fed conditions featuring the four
principal 13C-isotopomers of UDPG that are formed under the ex-
perimental conditions. Hexose and triose isotopomers are repre-
sented by connected circles with each black circle representing 13C
and each white circle representing 12C in the position of the mole-
cule indicated by the number above. The conversion of [1,2,3,-
13C3]dihydroxyacetone phosphate (DHAP) to [2,3,-13C2]3-phospho-
glyceric acid (3-PGA) via pyruvate, C4 Krebs cycle metabolites
(OAA/MAL/FUM), and the recycling of PEP to pyruvate, is repre-
sented by the dashed lines. The metabolic flux parameters shown in
bold are as follows: fglucose  fraction of G6P directly derived from
glucose; fglycerol  fraction of DHAP derived from glycerol; TPI 
triose phosphate isomerase exchange; TA  transaldolase ex-
change.
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tive branch of the PPP (15). The equations shown are
specific to 13C-isotopomers generated from the metabolism
of [1,2,3-13C3]glycerol but they can be applied to glucuro-
nide 13C-isotopomers from other gluconeogenic 13C-tracers
such as [1,2,3-13C3]propionate or [3-13C]lactate, or to gluc-
uronide specific activity measurements from 14C-gluconeo-
genic tracers. By formally redefining the source of unla-
beled G6P as glycogen instead of glucose, the model can be
applied to the fasted state. As illustrated in Fig. 1, [1,2,3-
13C3]glycerol can be converted to G6P via a relatively direct
pathway that involves entry into the triose phosphate pool
to form [1,2,3-13C3]triose P followed by the synthesis of
[1,2,3-13C3] or [4,5,6-13C3]hexose P via the aldolase reac-
tion. At low enrichment levels (5%), the probability of
forming hexose P from two [1,2,3-13C3]triose P molecules is
negligible. [1,2,3-13C3]Glycerol can also converted to G6P
by an indirect route that involves the conversion of tri-
ose-P to pyruvate followed by the anaplerotic resynthesis
of triose-P via pyruvate carboxylase and PEP carboxyki-
nase. As a result of label randomization and pyruvate
recycling via the Krebs cycle, the principal product of this
indirect pathway is [2,3-13C2]3-PGA with only minor
amounts of the [1,2,3-13C3]isotopomer.2 On this basis, it is
assumed that all [1,2,3-13C3]triose phosphate isotopomers
originated from [1,2,3-13C3]glycerol-3-phosphate (G3P) and
therefore entered the TPI reaction as [1,2,3-13C3]DHAP.
Meanwhile, all [2,3-13C2]triose phosphate isotopomers are
assumed to have originated from [2,3-13C2]3-PGA and
therefore entered the TPI reaction as [2,3-13C2]GA3P. The
isotopomers are assumed to be derived from a common
pool of hepatic triose phosphates. The formation of G6P
isotopomers from these two precursors are described by
the following equations:
[1,2,3-13C3]G6P  0.5  ([1,2,3-13C3]G3P  fglycerol)
 (1  (1-TPI))  (1 fglucose) [1]
[4,5,6-13C3]G6P  0.5  ([1,2,3-13C3]G3P  fglycerol)
 TPI  (1  (fglucose  (1-TA))) [2]
[1,2-13C2]G6P  0.5  [2,3-13C2]3-PGA  0.5
 (1  (0.5  fglycerol  (1  (1-TPI))))
 (1  fglucose) [3]
[5,6-13C2]G6P  0.5  [2,3-13C2]3-PGA  0.5
 (1  (0.5  fglycerol  (1  (1-TPI))))
 (1  (fglucose  (1-TA))) [4]
where: fglucose  fraction of G6P directly derived from glu-
cose; fglycerol  fraction of dihydroxyacetone phosphate
derived from glycerol-3-phosphate; TPI fraction of triose
phosphate molecules that underwent triose phosphate
isomerase exchange; TA  fraction of G6P molecules that
underwent transaldolase exchange; G3P  glycerol-3-
phosphate; 3-PGA  3-phosphoglyceric acid.
The equations can be rearranged to relate the metabolic
parameters to G6P isotopomer ratios:
[1,2,3-13C3]/[4,5,6-13C3]G6P  ((1  (1-TPI))
 (1  fglucose))/(TPI  (1  (fglucose  (1-TA)))) [5]
[1,2-13C2]/[5,6-13C2]G6P
 (1  (0.5  fglycerol  (1  (1-TPI)))
 (1  fglucose))/(1  (0.5  fglycerol
 (1  (1-TPI)))  (1  (fglucose  (1-TA)))) [6]
When exchange of GA3P with dihydroxyacetone phos-
phate (DHAP) is complete (TPI  1.0), the two isotopomer
ratios become equivalent and the equation simplifies as
follows:
[1,2,3-13C3]/[4,5,6-13C3]G6P  [1,2-13C2]/[5,6-13C2]G6P
 (1  fglucose)/(1  (fglucose  (1-TA))) [7]
Hepatic G6P 13C-isotopomer enrichments were quantified
from the 13C NMR multiplet signals of urinary glucuronide
after derivatization to MAGL. 13C-Enrichment of carbon 2
and the percent abundance of the [1,2,3-13C3]- and [1,2-
13C2]isotopomers were determined from the carbon 2 mul-
tiplet of MAGL. As illustrated by Fig. 2, the multiplet
component includes a central singlet signal (S), a quartet
arising from 13C-13C coupling of carbon 2 with both car-
bons 1 and 3 (Q), and a doublet due to 13C-13C-coupling
between carbons 1 and 2 (D). The contribution of each
component is expressed as a fraction of the total multiplet
area, arbitrarily given a value of 1.0. The singlet fraction
(S) is assumed to be derived from natural abundance 13C
and is assigned an enrichment value of 1.11%. For all
MAGL spectra this was confirmed by comparing the C2
and C5 singlet areas with those of the natural abundance
MAGL methyl signals. In each case the singlet area was
within 4% of the theoretical value (obtained from a human
MAGL preparation where no 13C-tracer was given). The Q
and D components represent the contributions of [1,2,3-
13C3]- and [1,2-13C2]G6P, respectively. On this basis the
carbon 2 13C-enrichment and isotopomer abundances were
calculated as follows.
Total carbon 2 enrichment (%)  1/S  1.11
Excess carbon 2 enrichment (%)
 Total carbon 2 enrichment–1.11
[1,2,3-13C3]G6P enrichment  Q/S  1.11
2[1,2,3-13C3]3-PGA is generated along with [2,3-13C2]3-PGA when [1,2,3-
13C3]triose-P is converted to [1,2,3-13C3]pyruvate via glycolysis and resynthe-
sized to triose-P via gluconeogenesis. Randomization by the Krebs cycle
generates equal amounts of [1,2,3-13C3]- and [2,3-13C2]PEP and the recycling
of PEP via pyruvate depletes the level of [1,2,3-13C3]- relative to [2,3-13C2]PEP
(14). Given that the abundance of [1,2-13C2]G6P is about 20% that of [1,2,3-
13C3]G6P, and assuming that pyruvate cycling is inactive, the maximal con-
tribution of [1,2,3-13C3]3-PGA to the total [1,2,3-13C3]triose-P pool is 20%. If
pyruvate cycling activity is the same as that reported for overnight fasting (15),
the contribution falls to 8%.
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[1,2-13C2]G6P enrichment  D/S  1.11
Analogous equations were derived for G6P carbon 5
enrichment and isotopomer abundances by analysis of the
MAGL carbon 5 multiplet:
Total carbon 5 enrichment (%)  1/S  1.11
Excess carbon 5 enrichment (%)
 Total carbon 5 enrichment–1.11
[4,5,6-13C3]G6P enrichment  Q/S  1.11
[5,6-13C2]G6P enrichment  D/S  1.11
The difference in isotopomer enrichment levels between
carbons 1, 2, 3 and 4, 5, 6 of glucuronide were analyzed by
the paired 2-tailed Student’s t-test. Differences were con-
sidered significant at P  0.05.
RESULTS
Model Predictions
The metabolic model relates TA and TPI exchanges to the
13C-isotopomer enrichment of the G3P triose moieties from
13C-enriched gluconeogenic precursors. These precursors
can enter the triose phosphate isomerase reaction as DHAP
(i.e., 13C-glycerol) or as GA3P (i.e., 13C-lactate). When TPI
exchange is incomplete the triose halves of G6P are en-
riched to unequal levels from either precursor substrate.
With tracers that enter as DHAP (for example [1,2,3-
13C3]glycerol), carbons 1, 2, and 3 of G6P will have higher
13C-enrichment than carbons 4, 5, and 6. With gluconeo-
genic tracers that enter as GA3P prior to TPI exchange (i.e.,
13C-lactate), the G6P enrichment pattern is reversed, with
carbons 4, 5, and 6 being more enriched than carbons 1, 2,
and 3. Under postabsorptive and fed conditions, the con-
tribution of glycerol carbons to total gluconeogenic flux is
small (5–10%). Therefore, for the simulated data shown in
Table 1 we assumed that 10% of DHAP flux was derived
from glycerol-3-P. Under these conditions, the effect of
incomplete TPI exchange on the inequality of 13C-enrich-
ment between the triose halves of G6P is relatively minor
with enriched GA3P precursors. In this study, GA3P is
enriched from the indirect metabolism of [1,2,3-
13C3]glycerol and is represented by [1,2]- and [5,6-
13C2]G6P. However, other tracers that are metabolized via
the Krebs cycle, such as 13C-lactate, will also generate
13C-enriched GA3P. For example, when TPI exchange is
80% complete the difference in 13C-enrichment levels be-
tween the triose moieties of G6P is only 2% (see Table 1).
However, for DHAP precursors the 13C-enrichment distri-
bution between the triose halves of G6P is far more sensi-
tive to the level of TPI exchange. As shown in Table 1, a
TPI exchange that is 80% complete results in a 50% higher
13C-enrichment in the 1,2,3-triose compared to the 4,5,6-
triose moiety of G6P. The addition of unlabeled G6P from
glucose will systematically dilute the 13C-enrichment lev-
els but it has no effect on the relative 13C-enrichments of
the G6P triose halves. When TPI exchange is complete the
triose halves of G6P are equivalently enriched regardless
of the 13C-tracer source.
TA exchange modifies the 13C-enrichment distribution
by exchanging an unlabeled carbon 4, 5, 6-moiety of F6P
with 13C-enriched GA3P. Therefore, regardless of whether
the tracer originated via GA3P or DHAP, the effect of TA
exchange is to increase the enrichment in carbons 4, 5, and
6 of G6P relative to carbons 1, 2, and 3. For a given level of
TA activity, the inequality between the 13C-enrichment of
the G6P triose halves becomes greater as the fraction of
G6P derived from unlabeled hexose sources (fglucose) is
increased.
Experimental Data
The MAGL derivative of urinary paracetamol glucuronide
provided high-resolution 13C NMR spectra of the carbon 2
and 5 13C-isotopomer signals of the glucuronide moiety
(14), as illustrated by the examples shown in Fig. 2. The
[1,2,3-13C3]- and [4,5,6-13C3]glucuronide isotopomer pair
derived from the incorporation of [1,2,3-13C3]glycerol into
G6P via glycerol kinase and triose phosphate intermedi-
ates are resolved as spin-spin coupled quartets within the
carbon 2 and 5 13C NMR signals. Enrichment from [1,2,3-
13C3]glucuronide was always less than that of [4,5,6-
13C3]glucuronide. This isotopomer distribution is opposite
to that predicted from incomplete TPI exchange (see Table
2) but is consistent with TA activity. The 13C NMR signals
of [1,2-13C2]- and [5,6-13C2]glucuronide, which represent
triose phosphate 13C-isotopomers derived via PEP and the
Krebs cycle, were also well resolved in the spectra, albeit
with low intensities. The observation of corresponding
[2,3-13C2]glutamine 13C-isotopomer signals from urinary
phenylacetylglutamine obtained from each subject is con-
FIG. 2. 13C NMR signals of carbons 2 and 5 from the monoacetone
glucuronic lactone derivative of paracetamol glucuronide from sub-
jects 3 and 5. The carbon 2 and 5 13C-resonances are shown in
expanded view and their multiplet components are labeled as fol-
lows: For carbon 2; S  natural abundance singlet, Q  quartet
signal from [1,2,3-13C3]glucuronide and D  doublet signal from
[1,2-13C2]glucuronide. For carbon 5; S  natural abundance singlet,
Q  quartet signal from [4,5,6-13C3]glucuronide and D  doublet
signal from [5,6-13C2]glucuronide. The ratio of [1,2,3-
13C3]glucuronide to [4,5,6-13C3]glucuronide (represented by C2Q/
C5Q) and [1,2-13C2]glucuronide to [5,6-13C2]glucuronide (repre-
sented by D12/D56) are also shown for both subjects.
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sistent with the hepatic Krebs cycle origins of [1,2-13C2]-
and [5,6-13C2]glucuronide (data not shown). Overall, the
ratio of [1,2-13C2]- to [5,6-13C2]glucuronide was in reason-
ably close agreement with that of [1,2,3-13C3]- to [4,5,6-
13C3]glucuronide. Because of the low D12 and D56 signal
intensities (a signal-to-noise ratio of 10:1 for the D12 sig-
nals of Subject 5), the [1,2-13C2]- to [5,6-13C2]glucuronide
ratio is associated with a higher level of uncertainty than
that of [1,2,3-13C3]- to [4,5,6-13C3]glucuronide.
As indicated by the simulated data of Table 1, the con-
cordance of these isotopomer ratios is consistent with TPI
exchange being 99% complete. Under these conditions
the simplified equation (Eq. [7]) can provide reasonable
estimates of TA exchange from the glucuronide 13C-isoto-
pomer ratios for a given fraction of direct pathway contri-
bution (fglucose) to G6P synthesis. For healthy subjects un-
der fed conditions, 50–70% of hepatic G6P is derived
directly from glucose (7,10,18). Assuming a direct path-
way contribution of 60%, the fraction of G6P undergoing
TA exchange was estimated for each subject, as shown in
Table 3. In addition, we calculated the apparent direct and
indirect pathway contributions that would be estimated
with glucose tracers that are diluted by TA exchange ([6-
14C]- and [5-3H]glucose).
The data indicate that for three of the subjects the extent
of TA exchange and its effects on direct and indirect path-
way estimates was relatively small. However, the remain-
ing two subjects had substantial TA exchange activities,
resulting in a sizeable overestimation of the indirect path-
way contribution to UDP-glucose synthesis. As shown by
the examples in Fig. 2, the smaller intensity of the carbon
2 multiplets relative to those of carbon 5 is quite sensitive
to the fraction of G6P undergoing TA activity. The unequal
intensities of the carbon 2 and 5 multiplets were also
accompanied by similar differences between the multip-
lets of glucuronide carbons 3 and 4 (data not shown).3
DISCUSSION
The labeling distribution of glucuronide from gluconeo-
genic tracers is influenced by both TPI and TA exchanges.
Depending on the source of the gluconeogenic tracer, the
effect of incomplete TPI exchange on the 13C-enrichment
distribution between the triose halves can either augment
or oppose that of TA. Therefore, in order to evaluate the
extent of TA activity the contribution of incomplete TPI
exchange to the enrichment distribution of glucuronide
has to be considered. In humans the formation of glucuro-
nide or glucose with unequal labeling of the triose halves
have been reported with several different 13C-and 14C-glu-
coneogenic tracers (19–21). Most of these measurements
were obtained after extended fasting when the fraction of
G6P derived from glycogenolysis is small. Under these
conditions the glucuronide or glucose labeling distribu-
tion is insensitive to TA activity but it is influenced by
incomplete TPI exchange. The distribution of radioactivity
from [2-14C]glycerol and [1-14C]lactate in the triose halves
of glucuronide was quantified in 36-hr fasted humans (20).
The specific activity from [2-14C]glycerol was 20%
higher in C2 compared to C5 of glucuronide, while the
specific activity from [1-14C]lactate was10% higher in C4
compared to C3. These observations are consistent with
hepatic TPI exchange being 90% complete. In individu-
als that were fasted for 60 hr and infused with 14C-propi-
onate or 14C-acetate, there was essentially equal distribu-
tion of label between the triose moieties of plasma glucose,
indicating near complete TPI exchange (8,21). However,
when [3-14C]lactate was infused under fed conditions the
specific activities of carbons 5 and 6 of glucose were 1.4–
1.6 times greater than those of carbons 1 and 2 and this was
attributed to a combination of TA activity and incomplete
TPI exchange (8). In light of our current findings and the
previously cited reports of near complete TPI exchange in
human liver, we conclude that the unequal specific activ-
ity distributions in the triose halves of glucose reported by
Magnusson et al. (8) are largely attributable to TA ex-
change. We applied the specific activity ratios of glucose
carbon 1 to carbon 6 and carbon 2 to carbon 5 to our model
using the same assumptions as for our 13C-isotopomer data
(i.e., 60% direct pathway contribution and complete TPI
exchange). This analysis revealed that in the study of
Magnusson et al. 33% of hepatic G6P had participated in
TA exchange.
The isotopomer analysis relies on the assumption that
flux through the oxidative portion of the PPP is negligible
3[2,3-13C2]Oxaloacetate is the main source of both hepatic [2,3-13C2]triose-P
and [2,3-13C2]glutamine.
Table 1
Theoretical G6P 13C-Isotopomer Ratios of [1,2,3-13C3]Glycerol Metabolism Derived from the Metabolic Flux Equations Using the
Metabolic Flux Parameter Values Shown. The [1,2]- and [5,6-13C2]G6P Isotopomers Represent Metabolism of [1,2,3-13C3]Glycerol via
Krebs Cycle and Glyceraldehyde-3-Phosphate Intermediates.
13C-Isotopomer ratios of G6P Metabolic flux parameters
[1,2,3-13C3]/[4,5,6-13C3]G6P [1,2-13C2]/[5,6-13C2]G6P fglycerol TPI fglucose TA
1.00 1.00 0.1 1.0 0.0 0.0
1.50 0.98 0.1 0.80 0.0 0.0
1.00 1.00 0.1 1.00 0.5 0.0
1.50 0.98 0.1 0.80 0.5 0.0
0.83 0.83 0.1 1.00 0.5 0.2
1.25 0.82 0.1 0.80 0.5 0.2
1.07 0.71 0.1 0.80 0.5 0.4
0.95 0.71 0.1 0.95 0.5 0.4
0.73 0.71 0.1 0.99 0.5 0.4
0.71 0.71 0.1 1.00 0.5 0.4
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in comparison to gluconeogenic fluxes (15). The presence
of oxidative PPP flux would have a significant effect on the
13C-isotopomer distributions of G6P. For example, the loss
of carbon 1 following the conversion of G6P to ribose-5-P
would initially generate [1,2-13C2] and [2-13C]ribose-5-P
from [1,2,3-13C3]- and [1,2-13C2]G6P, respectively. One
likely consequence is that PPP flux would significantly
alter the isotopomer ratio of [1,2-13C2]/[1,2,3-13C3]G-6-P
while that of [5,6-13C2]/[4,5,6-13C3]G6P would be relatively
unaffected. The fact that the experimental [1,2-13C2]/[1,2,3-
13C3]G-6-P and [5,6-13C2]/[4,5,6-13C3]G6P ratios were equal,
as seen in Table 2, is consistent with minimal PPP flux. In
two of the subjects the ratio of [1,2-13C2]/[5,6-13C2]G6P was
higher than that of [1,2,3-13C3]/[4,5,6-13C3]G6P. In the met-
abolic model, the ratio of [1,2-13C2]/[5,6-13C2]G6P can ap-
proach but not exceed that of [1,2,3-13C3]/[4,5,6-13C3]G6P.
Our experimental data may be a consequence of the high
uncertainty in quantifying the small [1,2-13C2]- and [5,6-
13C2]G6P NMR signals. Alternatively, these isotopomer
distributions may be real, therefore revealing a discrep-
ancy between the metabolic model and in situ fluxes. A
key assumption of the model is that all G6P isotopomers
originate from a common pool of gluconeogenic metabo-
lites, but it is well known that there is considerable met-
abolic heterogeneity between periportal and perivenal
hepatocytes, particularly regarding glycerol metabolism.
Glycerol is avidly metabolized by periportal cells, hence
the distribution of the two primary G6P isotopomers
([1,2,3-13C3] and [4,5,6-13C3]G6P) may be weighted toward
periportal TA activity. In comparison, the [1,2-13C2] and
[5,6-13C2]G6P isotopomer pair are derived via pyruvate/
lactate and therefore may reflect TA activity from a broader
region of the hepatic lobule, given the more homogenous
hepatic uptake of lactate/pyruvate compared to glycerol
(20). If TA activity in the pericentral/perivenous region
was lower than that of periportal cells, this would provide
an explanation for the [1,2-13C2]/[5,6-13C2]G6P ratio being
higher than that of [1,2,3-13C3]/[4,5,6-13C3]G6P.
The presence of TA activity has important implications
for quantifying the gluconeogenic contribution to human
hepatic G6P synthesis with either stable-isotope or radio-
active tracers, at least under fed conditions. Tracers such
as [5-3H]glucose or [6-13C]glucose undergo dilution as a
result of TA activity resulting in overestimates of the in-
direct pathway contribution to G6P synthesis. TA ex-
change does not result in the dilution of [1-13C]- or
[1-14C]glucose at the level of G6P; therefore, estimates of
direct and indirect pathway fractions with these tracers
will not be affected. With the 2H2O measurement of direct
and indirect pathway contributions (7), the fraction of G6P
derived from the indirect pathway is quantified as the ratio
of glucuronide hydrogen 5 enrichment relative to that of
body water. TA activity contributes to the enrichment of
Table 2
G6P 13C-Isotopomer Ratios Derived from 13C-NMR Isotopomer Analysis of Urinary Glucuronide of Five Healthy, Fed Subjects Following
Ingestion of [1,2,3-13C3]Glycerol and Paracetamol
Subject
Carbon 2 13C-enrichment and isotopomer
distribution of G6P
Carbon 5 13C-enrichment and isotopomer
distribution of G6P



















1 1.91 1.55 0.30 2.17 1.69 0.36 0.92 0.85
2 2.03 1.55 0.35 2.42 1.92 0.39 0.81 0.88
3 2.45 1.98 0.36 2.68 2.16 0.39 0.92 0.92
4 0.80 0.54 0.24 1.48 1.06 0.34 0.51 0.71
5 1.07 0.86 0.16 1.96 1.52 0.32 0.57 0.50
Mean 1.65 1.30 0.28 2.14 1.67 0.36 0.75 0.77
SD 0.68 0.57a 0.08b 0.46 0.42 0.03 0.19 0.17
aSignificantly less abundant than [4,5,6-13C3]glucuronide, P  0.05. bSignificantly less abundant than [5,6-13C2]glucuronide, P  0.05.
Table 3
Estimates of the Fraction of G6P Undergoing TA Exchange for the Five Subjects
Subject
Percentage of G6P that
underwent TA
exchange
Apparent percentage of UDP-glucose
derived from direct pathway (assuming a
theoretical value of 60%)
Apparent percentage of UDP-glucose
derived from indirect pathway
(assuming a theoretical value of 40%)
1 8 55 45
2 12 53 47
3 5 57 43
4 43 34 66
5 57 26 74
Mean ( SD) 25  23 45  14 55  14
TA was solved from Eq. [7] using the mean C2 and C5 isotopomer ratios and assuming a direct pathway fraction of 60% (fglucose  0.6) and
indirect pathway fraction of 40%. Triose phosphate isomerase exchange is assumed to be complete (TPI  1.0). Also shown are the
apparent direct and indirect pathway percentage contributions to UDP-glucose flux, and the deviations from the theoretical values that
would be obtained with tracers such as [5-3H]- or [6-13C]glucose.
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hydrogen 5, resulting in an overestimate of the indirect
pathway fraction (7).
In summary, transaldolase exchange is active in human
liver and it may result in significant overestimates of he-
patic gluconeogenic activity with 2H2O, gluconeogenic car-
bon tracers, or certain glucose tracers at least in the fed
state. Our data indicate that the unequal enrichment of the
triose moieties of G6P from 13C gluconeogenic tracers is
almost entirely attributable to transaldolase activity and
that transaldolase exchange can be quantified from the
relative 13C-enrichments of the G6P triose halves. With
gluconeogenic carbon tracers such as 13C-glycerol or 13C-
lactate, this information is inherent in the 13C-enrichment
distribution of plasma glucose or urinary glucuronide, and
hence in principle it could be used to correct for transal-
dolase activity.
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